Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
5195 ARTÍCULOS , VIENDO DEL 1696 AL 1710
Studying the Pathophysiology of Parkinson's Disease Using Zebrafish
Barnhill LM, Murata H, Bronstein JM.
Biomedicines. 2020 Jul 7;8(7):197. doi: 10.3390/biomedicines8070197.
Epigenetic Basis of Lead-Induced Neurological Disorders
Wang T, Zhang J, Xu Y.
Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878.
A Novel Mutation of PARK-2 Gene in a Patient with Early-onset Parkinson's Disease
Alafifi T, Bakhsh ARA, Elbashari M, Abouelnaga MEH, Eldimllawi AM.
Oman Med J. 2020 Jun 30;35(3):e140. doi: 10.5001/omj.2020.58. eCollection 2020 May.
Miglis MG, Muppidi S.
Clin Auton Res. 2020 Aug;30(4):287-289. doi: 10.1007/s10286-020-00712-2. Epub 2020 Jul 9.
Safinamide in the treatment of Parkinson's disease
Müller T.
Neurodegener Dis Manag. 2020 Aug;10(4):195-204. doi: 10.2217/nmt-2020-0017. Epub 2020 Jul 10.
Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease
Han L, Tang Y, Bai X, Liang X, Fan Y, Shen Y, Huang F, Wang J.
Aging (Albany NY). 2020 Jul 9;12(13):13518-13528. doi: 10.18632/aging.103458. Epub 2020 Jul 9.
Neurogenic Orthostatic Hypotension: An Underrecognized Complication of Parkinson Disease
Sin MK, Khemani P.
J Neurosci Nurs. 2020 Oct;52(5):230-233. doi: 10.1097/JNN.0000000000000528.
Purine molecules in Parkinson's disease: Analytical techniques and clinical implications
Von Seggern M, Szarowicz C, Swanson M, Cavotta S, Pike ST, Lamberts JT.
Neurochem Int. 2020 Oct;139:104793. doi: 10.1016/j.neuint.2020.104793. Epub 2020 Jul 7.
Role of Helicobacters in Neuropsychiatric Disease: A Systematic Review in Idiopathic Parkinsonism
Tucker RM, Augustin AD, Hayee BH, Bjarnason I, Taylor D, Weller C, Charlett A, Dobbs SM, Dobbs RJ.
J Clin Med. 2020 Jul 8;9(7):2159. doi: 10.3390/jcm9072159.
The Role of Oxidative Stress in Parkinson's Disease
Chang KH, Chen CM.
Antioxidants (Basel). 2020 Jul 8;9(7):597. doi: 10.3390/antiox9070597.
Discrete changes in brain volume after deep brain stimulation in patients with Parkinson's disease
Kern DS, Uy D, Rhoades R, Ojemann S, Abosch A, Thompson JA.
J Neurol Neurosurg Psychiatry. 2020 Sep;91(9):928-937. doi: 10.1136/jnnp-2019-322688. Epub 2020 Jul 10.
Dopamine-responsive and dopamine-resistant resting tremor in Parkinson disease
Zach H, Dirkx MF, Roth D, Pasman JW, Bloem BR, Helmich RC.
Neurology. 2020 Sep 15;95(11):e1461-e1470. doi: 10.1212/WNL.0000000000010316. Epub 2020 Jul 10.
The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When?
Dijk JM, Espay AJ, Katzenschlager R, de Bie RMA.
J Parkinsons Dis. 2020;10(s1):S65-S73. doi: 10.3233/JPD-202104.
What People with Parkinson's Disease Want
Andrejack J, Mathur S.
J Parkinsons Dis. 2020;10(s1):S5-S10. doi: 10.3233/JPD-202107.
Bjørklund G, Dadar M, Anderson G, Chirumbolo S, Maes M.
Pharmacol Res. 2020 Nov;161:105065. doi: 10.1016/j.phrs.2020.105065. Epub 2020 Jul 8.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.